ArthurYHungMD

Radiation Oncology • Portland, OR

Assistant Professor, Radiation Medicine, Oregon Health and Science University School of Medicine

Join to view full profile

Dr. Hung is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hung's full profile

Already have an account?

Office
3181 Sw Sam Jackson Park Rd
Portland, OR 97239
Phone+1 503-494-8756

Education & Training

University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 1998 - 2002
Saint Joseph HospitalResidency, Internal Medicine, 1997 - 1998
Ohio State University College of MedicineClass of 1997

Certifications & Licensure

OR State Medical License 2002 - 2025
WA State Medical License 2006 - 2015
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

Vascular Response to Brachytherapy Using Functional OCT Start of enrollment: 2013 Oct 01
Completed
Fluorothymidine F-18 PET in Diagnosing Patients With Intermediate or High Grade Soft Tissue Sarcoma Start of enrollment: 2020 Jun 01
Withdrawn
Early Phase 1

Publications & Presentations

PubMed

1 citations
On thin ice: Barriers to adoption of surveillance for patients with stage I testicular seminoma. Survey of US radiation oncologists
Aditya Jain, Catherine Degnin, Yiyi Chen, Mike Craycraft, Arthur Y. Hung
International Braz j Urol. 2018-05-01
28 citations
Multi-Institutional Implementation and Evaluation of a Curriculum for the Medical Student Clerkship in Radiation Oncology.
Daniel W. Golden, Steve Braunstein, Rachel B. Jimenez, Pranshu Mohindra, Alexander Spektor
Journal of the American College of Radiology. 2016-02-01
63 citations
Phase I trial of preoperative chemoradiation plus sorafenib for high-risk extremity soft tissue sarcomas with dynamic contrast-enhanced MRI correlates.
Janelle M. Meyer, Kelly Shea Perlewitz, James B. Hayden, Yee Cheen Doung, Arthur Y. Hung
Clinical Cancer Research. 2013-12-15

Authored Content

Perspectives from Council of Affiliated Regional Radiation Oncology SocietiesJune 2019
Perspectives from Council of Affiliated Regional Radiation Oncology SocietiesJune 2019